Genomic and clinical case characterisation of Staphylococcus haemolyticus isolated from dogs and cats in the United States, including strains with high‐level mupirocin tolerance
Veterinary Dermatology · 2023
DOI: 10.1111/vde.13154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Dermatology, 2023. Verfasst von Lindsey E Citron und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Cat Diseases, Staphylococcal Infections, Dog Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: This study was self-funded..
Abstract (Originalsprache)
Background
Staphylococcus haemolyticus is a coagulase‐negative commensal organism of both people and companion animals. It has pathogenic potential and when cultured is often meticillin‐ and multidrug‐resistant.
Objectives
To characterise the clinical features of dogs and cats with clinical skin disease that had positive S. haemolyticus skin cultures, and to employ whole‐genome sequencing (WGS) to identify resistance genes and characterise the genetic relatedness of strains. Materials and Methods Isolates were identified by the institutional clinical microbiology laboratory by routine aerobic culture and susceptibility from seven veterinary hospitals across the United States. Then, WGS and analysis of each isolate were performed and clinical data collected via a retrospective clinician questionnaire.
Results
S. haemolyticus was identified from superficial (seven of 12) and deep (five of 12) cutaneous infections in our study. Most animals had received antimicrobials (10 of 12) and/or immunomodulatory drugs (nine of 12) within the six months before culture. WGS analysis revealed a variety of genetic lineages and a wide array of antimicrobial resistance genes. Meticillin resistance was identified in nine of 12 isolates and four of 12 isolates demonstrated mupirocin tolerance. Conclusions and Clinical Relevance Staphylococcus haemolyticus may be an under‐recognised pathogen in companion animals, and its demonstrated potential for multidrug‐resistance, meticillin‐resistance, and high‐level mupirocin tolerance may create a therapeutic challenge. Further studies should evaluate the prior antimicrobial use and immunocompromised status as risk factors for infection with S. haemolyticus .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Christine L Cain, Jaclyn Dietrich, Stephen D Cole
Förderung
- This study was self-funded.
Zitieren
APA
Citron, L. E., Cain, C. L., Dietrich, J., & Cole, S. D. (2023). Genomic and clinical case characterisation of Staphylococcus haemolyticus isolated from dogs and cats in the United States, including strains with high‐level mupirocin tolerance. Veterinary Dermatology. https://doi.org/10.1111/vde.13154
Vancouver
Citron LE, Cain CL, Dietrich J, Cole SD. Genomic and clinical case characterisation of Staphylococcus haemolyticus isolated from dogs and cats in the United States, including strains with high‐level mupirocin tolerance. Veterinary Dermatology. 2023. doi:10.1111/vde.13154
BibTeX
@article{Citron2023,
author = {Citron, Lindsey E and Cain, Christine L and Dietrich, Jaclyn and Cole, Stephen D},
title = {Genomic and clinical case characterisation of Staphylococcus haemolyticus isolated from dogs and cats in the United States, including strains with high‐level mupirocin tolerance},
journal = {Veterinary Dermatology},
year = {2023},
doi = {10.1111/vde.13154}
}
EUVIMED